2007
DOI: 10.1136/gut.2006.115873
|View full text |Cite
|
Sign up to set email alerts
|

Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
88
0
4

Year Published

2008
2008
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(95 citation statements)
references
References 20 publications
2
88
0
4
Order By: Relevance
“…31 The systematic review and meta-analysis undertaken by our group 31 substantially builds on the initial very important review by Heyland et al 9 by including seven new trials, including the first four multi-centre randomised controlled trials in this area of research. [32][33][34][35] This updated review 31 indicates and supports previous findings 9 that micronutrient supplementation in the critically ill may be associated with a reduction in overall mortality, and specifically 28 day mortality.…”
Section: Synthesis Of the Evidencesupporting
confidence: 57%
See 1 more Smart Citation
“…31 The systematic review and meta-analysis undertaken by our group 31 substantially builds on the initial very important review by Heyland et al 9 by including seven new trials, including the first four multi-centre randomised controlled trials in this area of research. [32][33][34][35] This updated review 31 indicates and supports previous findings 9 that micronutrient supplementation in the critically ill may be associated with a reduction in overall mortality, and specifically 28 day mortality.…”
Section: Synthesis Of the Evidencesupporting
confidence: 57%
“…35 This study by Siriwardena et al, 35 conducted in patients with severe acute pancreatitis, indicated a trend towards worse outcome in the treatment arm of the study (although results were not statistically significant and not demonstrably treatment related). The outcome of this study warrants caution, at least in patients with severe acute pancreatitis.…”
Section: Synthesis Of the Evidencementioning
confidence: 99%
“…Recently, Siriwardena et al (36) reported a nicely designed randomized, double-blinded, placebo-controlled trial on intravenous antioxidant treatment for SAP. The study was performed on patients with predicted SAP, managed according to the United Kingdom guidelines for the management of AP (26), and the authors found that antioxidant supplementation was not useful to avoid MOF, ameliorate patient outcomes or reduce length of hospital stay.…”
Section: Discussionmentioning
confidence: 99%
“…The first study was performed on 84 patients and showed increased recovery rate, improved cellular immune function as well as reduced rate of complications and LOS in the intervention group [44]. In the second study of 43 patients, vitamin C, selenium, and n-acetylcystein treatment did not improve organ function, mortality, and LOS and did not reduce oxidative stress [45]. Three other RCTs investigated the effect of n-3 fatty acids supplementation in oncology patients.…”
Section: Micronutrients and Other Nutrients Requirementsmentioning
confidence: 99%